Interaction between brain natriuretic peptide and atrial natriuretic peptide in caecal circular smooth muscle cells.

作者: Osamu Yasuda , Yoshiharu Chijiiwa , Yasuaki Motomura , Toshiaki Ochiai , Hajime Nawata

DOI: 10.1016/S0167-0115(99)00101-9

关键词: CyclaseProtein kinase ANPR1MyocyteAtrial natriuretic peptideInternal medicineBrain natriuretic peptideNPR2EndocrinologyNatriuretic peptideBiology

摘要: Guinea pig caecal circular smooth muscle cells were used to determine whether brain natriuretic peptide (BNP) can inhibit the contractile response produced by cholecystokinin-octapeptide (CCK-8). In addition, we examined effect of an inhibitor cAMP-dependent protein kinase, particulate or soluble guanylate cyclase, atrial (ANP) antagonist (ANP 1-11), and selective receptor protection on BNP-induced relaxation these cells. The BNP cAMP formation was also examined. inhibited CCK-8 in a dose-response manner, with IC50 value 8.5 nM, stimulated production cAMP. kinase cyclase significantly BNP. contrast, did not have any significant ANP 1-11 but partially where binding sites protected completely preserved inhibitory ANP, both This study demonstrates that induces via coupled distinct adenylate cyclase.

参考文章(52)
Increased human brain natriuretic peptide in congestive heart failure The New England Journal of Medicine. ,vol. 323, pp. 757- 758 ,(1990) , 10.1056/NEJM199009133231114
B.D. Bennett, G.L. Bennett, R.V. Vitangcol, J.R. Jewett, J. Burnier, W. Henzel, D.G. Lowe, Extracellular domain-IgG fusion proteins for three human natriuretic peptide receptors. Hormone pharmacology and application to solid phase screening of synthetic peptide antisera. Journal of Biological Chemistry. ,vol. 266, pp. 23060- 23067 ,(1991) , 10.1016/S0021-9258(18)54463-X
B. M. Brenner, B. J. Ballermann, M. E. Gunning, M. L. Zeidel, Diverse biological actions of atrial natriuretic peptide Physiological Reviews. ,vol. 70, pp. 665- 699 ,(1990) , 10.1152/PHYSREV.1990.70.3.665
H Ruskoaho, Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacological Reviews. ,vol. 44, pp. 479- 602 ,(1992)
F Fuller, J G Porter, A E Arfsten, J Miller, J W Schilling, R M Scarborough, J A Lewicki, D B Schenk, Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. Journal of Biological Chemistry. ,vol. 263, pp. 9395- 9401 ,(1988) , 10.1016/S0021-9258(19)76554-5
Hironobu MORITA, Masanobu HAGIIKE, Takao HORIBA, Keisuke MIYAKE, Hideo OHYAMA, Hideo YAMANOUCHI, Hiroshi HOSOMI, Kenji KANGAWA, Naoto MINAMINO, Hisayuki MATSUO, Effects of brain natriuretic peptide and C-type natriuretic peptide infusion on urine flow and jejunal absorption in anesthetized dogs. Japanese Journal of Physiology. ,vol. 42, pp. 349- 353 ,(1992) , 10.2170/JJPHYSIOL.42.349
S Suga, K Nakao, K Hosoda, M Mukoyama, Y Ogawa, G Shirakami, H Arai, Y Saito, Y Kambayashi, K Inouye, Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. ,vol. 130, pp. 229- 239 ,(1992) , 10.1210/ENDO.130.1.1309330
M Yoshimura, H Yasue, E Morita, N Sakaino, M Jougasaki, M Kurose, M Mukoyama, Y Saito, K Nakao, H Imura, Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure Circulation. ,vol. 84, pp. 1581- 1588 ,(1991) , 10.1161/01.CIR.84.4.1581